<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02452541</url>
  </required_header>
  <id_info>
    <org_study_id>PEJ-679</org_study_id>
    <nct_id>NCT02452541</nct_id>
  </id_info>
  <brief_title>TBI-Prognosis Multicenter Prospective Study</brief_title>
  <official_title>Early Determination of Neurological Prognosis in ICU Patients With Severe Traumatic Brain Injury: The TBI-Prognosis Multicenter Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Critical Care Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CHU de Quebec-Universite Laval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe traumatic brain injury (TBI) is the leading cause of death and disability among people
      under 45 years of age and a major public health problem. Although management of severe TBI
      patients has gradually improved with the establishment of intensive care units (ICU) and the
      development of practice guidelines, mortality is still high - ranging from 30 to 50% - with
      30% of survivors suffering from severe neurological sequelae such as neurovegetative states.
      Families and medical teams are frequently called upon to determine reasonable and appropriate
      goals of care for brain injured patients. They may have to consider high intensity of care,
      but also the withdrawal of life-sustaining therapies in accordance with patient wishes.
      Physicians involved in the care of severe traumatic brain injury have expressed serious
      concerns about hasty decisions made in the absence of appropriate evidence of unfavourable
      prognosis. The purpose of the TBI-Prognosis study is to develop a prognostic model by using a
      multimodal approach of different prognostic indicators and their evolution over time in the
      acute phase of care. The results of this study will provide better objective information that
      will facilitate the shared-decision making-process with families and relatives.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glasgow Outcome Scale Extended</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>EuroQuol - EQ-5D-5L</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow Outcome Scale Extended</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">315</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Prognostic evaluation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Prognostic tests/exams performed according to a determined schedule during the acute phase of care following admission in the intensive care unit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prognostic tests</intervention_name>
    <description>Brain CT-Scan on day 1, 3 and 7
Brain MRI on day 7
SomatoSensory Evoked Potentials on day 7
Electroencephalogram on day 7
Serum biomarkers on day 1, 3 and 7
Daily clinical exams</description>
    <arm_group_label>Prognostic evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (≥ 18 years) with severe blunt TBI admitted to the ICU

          -  All patients with a GCS ≤ 8 after initial resuscitation

        Exclusion Criteria:

          -  Anticipated being on mechanical ventilation for &lt; 48 hour period due to an altered
             level of consciousness related to the TBI plus another potentially reversible factor
             (i.e. drugs, substance abuse, excessive sedation, etc.).

          -  Solid malignancy with a life expectation &lt;12 months

          -  Liver cirrhosis Child C

          -  Chronic heart failure (NYHA class IV)

          -  End-stage chronic respiratory disease (O2 dependent)

          -  End-stage renal disease (initiated or expectant chronic dialysis or to be expected)

          -  Previous neurologic disorder with abnormal findings (such as a mass lesion) on
             radiological imaging (CT-scan, MRI) or electrophysiological tests (EEG, SSEP) (such as
             previous uncontrolled epilepsy, significant stroke, previous or acute concomitant
             spinal cord injury, etc)

          -  Patients with no fixed address will be excluded because of the difficult follow-up

          -  Physician refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis Turgeon, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Quebec Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Foothills Health Sciences Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Health - Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Health - University Of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Columbian Hospital</name>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Jubilee Hospital</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winnipeg Health Sciences Center</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences Center</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ST. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Sacré-Coeur de Montréal</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Québec - Hôpital de l'Enfant-Jésus</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Sherbrooke - Hôpital Fleurimont</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.tbi-prognosis.ca/</url>
    <description>Click here for more information about this study: TBI-Prognosis Multicenter Prospective Study</description>
  </link>
  <link>
    <url>http://www.ccctg.ca/Programs/TBI-Prognosis.aspx</url>
    <description>Click here for more information about this study: TBI-Prognosis Multicenter Prospective Study and the Canadian Critical Care Trials Group</description>
  </link>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2015</study_first_submitted>
  <study_first_submitted_qc>May 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 22, 2015</study_first_posted>
  <last_update_submitted>June 7, 2016</last_update_submitted>
  <last_update_submitted_qc>June 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHU de Quebec-Universite Laval</investigator_affiliation>
    <investigator_full_name>Alexis Turgeon</investigator_full_name>
    <investigator_title>MD MSc FRCPC</investigator_title>
  </responsible_party>
  <keyword>Traumatic Brain Injury</keyword>
  <keyword>Critically ill Patients</keyword>
  <keyword>Death</keyword>
  <keyword>Head Injury</keyword>
  <keyword>TBI-Prognosis</keyword>
  <keyword>Critical Care Medicine</keyword>
  <keyword>Withdrawal of Life Sustaining Therapy</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Prognostic Evaluation</keyword>
  <keyword>Outcome Research</keyword>
  <keyword>Mortality</keyword>
  <keyword>Decision-making</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

